These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 27608437

  • 41. Safety and tolerability of adjunctive brivaracetam in children with focal seizures: Interim analysis of pooled data from two open-label trials.
    Patel AD, Badalamenti V, Gasalla T, Elmoufti S, Elshoff JP.
    Eur J Paediatr Neurol; 2020 Mar; 25():68-76. PubMed ID: 31810577
    [Abstract] [Full Text] [Related]

  • 42. Efficacy, retention, and safety of brivaracetam in adult patients with genetic generalized epilepsy.
    Fonseca E, Guzmán L, Quintana M, Abraira L, Santamarina E, Salas-Puig X, Toledo M.
    Epilepsy Behav; 2020 Jan; 102():106657. PubMed ID: 31731108
    [Abstract] [Full Text] [Related]

  • 43. The efficacy and safety of brivaracetam at different doses for partial-onset epilepsy: a meta-analysis of placebo-controlled studies.
    Tian X, Yuan M, Zhou Q, Wang X.
    Expert Opin Pharmacother; 2015 Jan; 16(12):1755-67. PubMed ID: 26165169
    [Abstract] [Full Text] [Related]

  • 44. Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double-blind, phase III studies.
    Steinhoff BJ, Patten A, Williams B, Malhotra M.
    Epilepsia; 2020 Feb; 61(2):278-286. PubMed ID: 31944276
    [Abstract] [Full Text] [Related]

  • 45. Prevention of generalized tonic-clonic seizures in refractory focal epilepsy: a meta-analysis.
    Hemery C, Ryvlin P, Rheims S.
    Epilepsia; 2014 Nov; 55(11):1789-99. PubMed ID: 25182978
    [Abstract] [Full Text] [Related]

  • 46. Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis.
    Lattanzi S, Trinka E, Zaccara G, Striano P, Russo E, Del Giovane C, Silvestrini M, Brigo F.
    Drugs; 2022 Feb; 82(2):199-218. PubMed ID: 35061214
    [Abstract] [Full Text] [Related]

  • 47. Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
    Brigo F, Bragazzi NL, Nardone R, Trinka E.
    Seizure; 2016 Nov; 42():29-37. PubMed ID: 27710868
    [Abstract] [Full Text] [Related]

  • 48. Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures.
    Mumoli L, Palleria C, Gasparini S, Citraro R, Labate A, Ferlazzo E, Gambardella A, De Sarro G, Russo E.
    Drug Des Devel Ther; 2015 Nov; 9():5719-25. PubMed ID: 26543353
    [Abstract] [Full Text] [Related]

  • 49. Time course of 75%-100% efficacy response of adjunctive brivaracetam.
    Klein P, Laloyaux C, Elmoufti S, Gasalla T, Martin MS.
    Acta Neurol Scand; 2020 Aug; 142(2):175-180. PubMed ID: 32432339
    [Abstract] [Full Text] [Related]

  • 50. Efficacy and safety of perampanel in generalized and focal to bilateral tonic-clonic seizures: A comparative study of Asian and non-Asian populations.
    Nishida T, Lee SK, Wu T, Tiamkao S, Dash A.
    Epilepsia; 2019 Mar; 60 Suppl 1():47-59. PubMed ID: 30869168
    [Abstract] [Full Text] [Related]

  • 51. Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany.
    Steinig I, von Podewils F, Möddel G, Bauer S, Klein KM, Paule E, Reif PS, Willems LM, Zöllner JP, Kunz R, Runge U, Kurlemann G, Schubert-Bast S, Rosenow F, Strzelczyk A.
    Epilepsia; 2017 Jul; 58(7):1208-1216. PubMed ID: 28480518
    [Abstract] [Full Text] [Related]

  • 52. Long-term safety and efficacy of adjunctive brivaracetam in pediatric patients with epilepsy: An open-label, follow-up trial.
    Lagae L, Klotz KA, Fogarasi A, Floricel F, Reichel C, Elshoff JP, Fleyshman S, Kang H.
    Epilepsia; 2023 Nov; 64(11):2934-2946. PubMed ID: 37597326
    [Abstract] [Full Text] [Related]

  • 53. Health-related quality of life in double-blind Phase III studies of brivaracetam as adjunctive therapy of focal seizures: A pooled, post-hoc analysis.
    Brandt C, Borghs S, Elmoufti S, Mueller K, Townsend R, de la Loge C.
    Epilepsy Behav; 2017 Apr; 69():80-85. PubMed ID: 28236727
    [Abstract] [Full Text] [Related]

  • 54. Long-term safety, efficacy, and quality of life during adjunctive brivaracetam treatment in patients with uncontrolled epilepsy: An open-label follow-up trial.
    Toledo M, Brandt C, Quarato PP, Schulz AL, Cleveland JM, Wagener G, Klein P.
    Epilepsy Behav; 2021 May; 118():107897. PubMed ID: 33780735
    [Abstract] [Full Text] [Related]

  • 55. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
    Delanty N, Jones J, Tonner F.
    Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
    [Abstract] [Full Text] [Related]

  • 56. Brivaracetam for the treatment of refractory epilepsy in patients with prior exposure to levetiracetam: A retrospective outcome analysis.
    Snoeren A, Majoie MHJM, Fasen KCFM, Ijff DM.
    Seizure; 2022 Mar; 96():102-107. PubMed ID: 35184005
    [Abstract] [Full Text] [Related]

  • 57. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial.
    Krauss GL, Klein P, Brandt C, Lee SK, Milanov I, Milovanovic M, Steinhoff BJ, Kamin M.
    Lancet Neurol; 2020 Jan; 19(1):38-48. PubMed ID: 31734103
    [Abstract] [Full Text] [Related]

  • 58. Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy-A monocenter survey.
    Steinhoff BJ, Bacher M, Bucurenciu I, Hillenbrand B, Intravooth T, Kornmeier R, Kurth C, Stockinger J, Staack AM.
    Seizure; 2017 May; 48():11-14. PubMed ID: 28364655
    [Abstract] [Full Text] [Related]

  • 59. Efficacy and safety of adjunctive lacosamide for the treatment of partial-onset seizures in Chinese and Japanese adults: A randomized, double-blind, placebo-controlled study.
    Hong Z, Inoue Y, Liao W, Meng H, Wang X, Wang W, Zhou L, Zhang L, Du X, Tennigkeit F, EP0008 Study Group.
    Epilepsy Res; 2016 Nov; 127():267-275. PubMed ID: 27669155
    [Abstract] [Full Text] [Related]

  • 60. Brivaracetam effectiveness and tolerability in older and younger adults with epilepsy: EXPERIENCE, a pooled analysis of international data from retrospective studies.
    Faught E, Besson H, D'Souza W, Klein P, Reuber M, Rosenow F, Salas-Puig J, Insuga VS, Steinhoff BJ, Strzelczyk A, Szaflarski JP, Bourikas D, Daniels T, Floricel F, Friesen D, Laloyaux C, Villanueva V.
    Epilepsy Behav; 2024 Sep; 158():109922. PubMed ID: 38970892
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.